Study identifier:D1843R00356
ClinicalTrials.gov identifier:NCT06123858
EudraCT identifier:N/A
CTIS identifier:N/A
Non-alcoholic steatohepatitis registry platform study
NASH with fibrosis
N/A
No
-
All
2500
Observational
18 Years - 75 Years
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
NASH with fibrosis NASH patients with fibrosis receiving routine treatment | - |